In this episode of Clinical Chats, the CTC-SRH speaks with Amy Weber, WHNP, to discuss the Denver Sexual Health Clinic’s approach to STI express visits for patients. They explore how the clinic streamlines STI testing, result management, and treatment supported by Title X funding, while also addressing implementation challenges and space for future innovations.

In this episode of Clinical Chats, the CTC-SRH team speaks with Anna Newton-Levinson, PhD, MPH, and Marilyn Johnson, MBA, presenters at the 2025 National Reproductive Health Conference, about burnout and resilience in sexual and reproductive health settings.

In this episode of Clinical Chats, our CTC-SRH hosts speak with Jonathan Baker, PA-C, MPAS, one of the speakers for the 2025 Virtual National Reproductive Health Conference, to discuss the importance of addressing anal health in Title X settings. The conversation focuses on anal pathology and provides an introduction to what Title X clinicians should know about this topic, including anal cancer screening guidelines, sample collection methods, and strategies for discussing risk factors with patients.

This Clinical Chats podcast episode features Dr. Aletha Akers, a national expert in adolescent sexual and reproductive healthcare, with hosts Dr. Kristin Metcalf-Wilson and Dr. Tammy Bennett. In this episode, Dr. Akers provides insights into best practices for healthcare providers when caring for adolescents, including making practices adolescent-friendly, navigating confidentiality, and utilizing screening tools and scripts. This episode aims to enhance the knowledge of sexual and reproductive health professionals, particularly Title X clinicians.

In this episode, the CTC-SRH welcomes you to a new season of Clinical Chats. The CTC-SRH Program Director, Dr. Kristin Metcalf-Wilson, and Associate Director, Dr. Tammy Bennett, introduce themselves as the new hosts of clinical interviews with experts across the sexual and reproductive health field. Listeners are encouraged to reach out to info@ctcsrh.org with topics or questions they would like to hear discussed in the upcoming season.

The CTC-SRH speaks with one of the keynote speakers for the upcoming National Reproductive Health Conference, Dr. Raegan McDonald-Mosley, CEO of Power To Decide, about contraceptive access and equity in the US today.

The CTC-SRH speaks with one of the presenters for the upcoming National Reproductive Health Conference, Dr. Rachel McKean, a Complex Family Planning Fellow at Penn Medicine, about providing pain management during IUD insertions and other gynecological procedures that are performed in office settings.

The CTC-SRH speaks with one of the presenters for the upcoming National Reproductive Health Conference, Dr. Brandon Mizroch from the AIDS Education Training Center at the University of Utah Hospital, about conducting an HIV risk assessment in family planning settings and providing follow-up care.

As part of the Combatting Congenital Syphilis trilogy, the CTC-SRH speaks with Michael Carter and Ariel Johnson, a regional manager of STD Control and disease intervention specialist/contact tracer, respectively, from the Louisiana Department of Health, about their roles in addressing syphilis and HIV and how clinicians and DIS can leverage relationships to help their communities.

In response to the rising rates of congenital syphilis infections, the CTC-SRH speaks with Dr. Kate Miele from the Centers for Disease Control and Prevention to review conventional testing and treatment protocols for syphilis. 

In response to the rising rates of congenital syphilis infections, the CTC-SRH's own Associate Director, Tammy Bennett, discusses point-of-care testing and same day treatment for syphilis infections, and how Title X sites can implement these services in their own clinics.

In the final episode of the four-part series on the pregnancy-associated death crisis in the US, The CTC-SRH speaks with Dr. Nicole Tchalim, from Columbia University's Women and Reproductive Mental Health, or WARM, program, and how Title X and other family planning clinicians can address mental health struggles and suicidality in their own patients.

In part three of a four-part series, the CTC-SRH speaks with Dr. Karen Trister Grace about the effects of intimate partner violence on pregnancy, homicide as a cause of pregnancy-associated death, and how Title X clinicians can address it in their practices.

In the second of the four-part series on the pregnancy-associated death crisis in the US, The CTC-SRH speaks with Dr. Tricia Wright from UCSF about the role substance use disorder and overdoses play in these death rates, and how Title X and other family planning clinicians can help prevent overdose in their own patients.

In this first of a multi-episode series, the CTC-SRH talks with epidemiologist Dr. Maeve Wallace about pregnancy-associated deaths in the US, how often they happen, and the top causes, and what this information means for Title X practitioners and staff.

The CTC-SRH talks with Robin Summers, JD senior counsel and vice president at the National Family Planning and Reproductive Health Association, about the recent federal ruling in Ohio v. Becerra.  Robin interprets the current ruling for listeners and provides insight about what Title X providers and staff can anticipate next in the case.

As part of the 2023 Clinician Cafe, the CTC-SRH speaks with Dr. Mishka Terplan about harm reduction, its role in sexual and reproductive healthcare, and guidance for clinicians on substance use, misuse, and harm reduction counseling.

In the latest installment of the ongoing series, Coding with Ann, Ann Finn, of Ann Finn LLC, discusses updated guidance on common LARC miscodes with the CTC-SRH.

In the final installment of the CTC-SRH's series on reproductive justice issues and Title X services, The CTC-SRH speaks with Dr. Dominika Seidman on HIV, pregnancy, and reproductive justice, and how Title X providers can provide counseling on pregnancy and family building that is evidence-based and client-centered.

The CTC-SRH talks with Anitra Beasley, MD, MPH, about the FDA's recent decision to approve OPill to be the first hormonal contraceptive pill to be available over-the-counter.